INTRODUCTION {#s1}
============

Coronary artery disease (CAD) remains the leading cause of mortality and morbidity in Western countries \[[@R1]\]. Invasive coronary angiography is currently the gold standard for diagnosis and treatment of CAD; however, it is an invasive procedure associated with risks and complications \[[@R2]\]. Moreover, it is reported that around 20% to 40% of all diagnostic invasive coronary angiography procedures were performed for diagnostic purposes without any interventional procedures being applied \[[@R3]--[@R5]\]. Thus, investigation of less invasive imaging modalities is important for reducing or avoiding the use of invasive coronary angiography examinations \[[@R4]\].

Currently, multislice computed tomography (CT) angiography is widely used in clinical practice for the diagnosis of CAD, and its diagnostic accuracy has been significantly enhanced with the recent development of 64-, 256- and 320-slice scanners \[[@R6]--[@R9]\]. Studies have shown that multislice CT angiography can be used as a reliable alternative to invasive coronary angiography in selected patients, due to its high sensitivity and specificity \[[@R6]--[@R9]\].

Myocardial perfusion imaging with SPECT is a widely established method for non-invasive evaluation of coronary artery stenosis \[[@R10]\]. However, the most important applications of SPECT are in the diagnosis of CAD, prediction of disease prognosis, selection of patients for revascularisation and assessment of acute coronary syndromes. Moreover, SPECT holds special value in some particular patient subgroups \[[@R11], [@R12]\]. Generally speaking, the sensitivity of stress SPECT for detecting angiographically-defined CAD is consistently above 70%, but in the better-designed studies, it is within the range of 85--90% \[[@R13], [@R14]\].

Positron emission tomography (PET) has contributed significantly to advancing our understanding of heart physiology and pathophysiology for more than 25 years. The diagnostic accuracy of myocardial perfusion by PET in the assessment of CAD has been reported to be superior to SPECT \[[@R15], [@R16]\]. PET with rest-stress myocardial perfusion is regarded as an exact imaging modality for diagnosing and managing patients with CAD \[[@R16]\]. Moreover, the combined modality of PET/CT further increases the diagnostic accuracy in CAD \[[@R12]--[@R16]\].

Despite promising results reported in the literature \[[@R17], [@R18]\], the diagnostic value of SPECT and PET to detect CAD has not been well established. This is mainly due to the fact that the diagnostic accuracy reported by these studies is variable and the radiopharmaceuticals used in these studies are different. Thus, the purpose of our study was to investigate the diagnostic value of SPECT, PET and PET/CT when compared to invasive coronary angiography for detection of CAD, based on a systematic review of the current literature.

MATERIALS AND METHODS {#s2}
=====================

A search of the English-language literature was performed using two main databases, PubMed/Medline and ScienceDirect. The search included articles published between 1985 and 2009 on the topics of SPECT, PET and PET/CT in CAD. The research was limited to peer-reviewed articles on human subjects and studies published in the English language. The keywords used for the search were "Positron Emission Tomography", "Single Photon Emission Computed Tomography", "integrated Positron Emission Tomography and Computed Tomography", "Coronary Artery Disease", "Myocardial perfusion", "Nuclear Medicine Imaging in cardiac disease". The reference lists for studies matching these criteria were also reviewed to identify additional articles which were not found through the initial search. The last search was performed in September 2010 to ensure inclusion of all recent publications in the analysis.

Articles that met the following criteria were included for analysis: SPECT, PET, or PET/CT studies were performed in patients who underwent myocardial perfusion imaging (MPI) rest/stress test while invasive coronary angiography was used as the standard of reference; at least ten patients were included in each study; diagnosis of CAD was based on \>50% stenosis. The reason \>50% stenosis was chosen was because it has become a routine clinical practice to consider coronary stenosis \>50% as haemodynamically significant \[[@R19]--[@R21]\]. Also, the diagnostic value in terms of sensitivity and specificity was reported in the study. The exclusion criteria included: review articles or case study reports; animal or phantom studies; studies dealing with myocardial perfusion without addressing the diagnostic accuracy of coronary artery stenosis or occlusion, and studies including patients treated with coronary stents or bypass grafts.

Two reviewers checked the references independently and the following information was extracted from each study: year of publication; number of participants in the study; prevalence of patients with suspected or confirmed CAD; mean age; percentage of male patients affected; type of radiotracer used in each study; rest and stress imaging protocols; diagnostic value of SPECT, PET and PET/CT in terms of sensitivity and specificity; and the accuracy of SPECT, PET and PET/CT for detection of CAD. The main findings were summarised in terms of the extent to which studies were reported to have shown the value of using SPECT, PET and PET-CT to diagnose CAD towards improving patient management and cost-effectiveness.

All of the statistical analyses were undertaken using SPSS software version 17.0 (SPSS Inc., Chicago, ILL). Each of the study estimates for sensitivity and specificity were independently combined across studies using one sample test. Comparison was performed by Chi Square test using n-1 degree of freedom to test if there are any significant differences between different imaging modalities (SPECT vs PET, SEPCT vs PET/CT, PET vs PET/CT). Statistical hypotheses (2-tailed) were tested at the 5% level of significance.

RESULTS {#s3}
=======

Twenty-five studies (with 25 comparisons) met the selection criteria and were included in the analysis \[[@R19]--[@R43]\]. Ten of these studies were performed with SPECT alone \[[@R19]--[@R24], [@R39]--[@R41], [@R43]\], while six of the studies were performed with PET alone \[[@R30]--[@R35]\]. Five studies were carried out with both PET and SPECT modalities \[[@R25]--[@R29]\] and the remaining four studies were investigated with integrated PET/CT \[[@R36]--[@R38], [@R42]\]. The total number of patients included in these studies was 4,114 with 53.5% of the patients suspected of CAD, 72.2 % being male and the mean age of patients being 48-years-old. [Table 1](#T1){ref-type="table"} summarises the number of patients, the radiotracers used in each study, and the reported sensitivity, specificity and accuracy with use of SPECT, PET and PET/CT imaging modalities, respectively.

###### 

Study characteristics of SPECT, PET and PET/CT for detection of coronary artery disease

  **Authors**              **Year**   **Patients (n)**   **Male (%)**   **Mean age (yr)**   **Stenosis**   **Radiotracer**                     **Sensitivity**   **Specificity**   **Accuracy**
  ------------------------ ---------- ------------------ -------------- ------------------- -------------- ----------------------------------- ----------------- ----------------- --------------
  Husmann et al^16^        2008       80                 85             36                  \>50%          ^201^Thallium                       77%               84%               NA
  Fallahi et al^20^        2008       51                 85             34                  NA             ^99m^Tc-sestamibi                   91%               71%               88%
  Di Carli et al^35^       2007       110                54.5           57.3                \>50%          ^82^Rubidium                        65%               75%               NA
  Cesar et al^36^          2007       281                51.6           38.3                \>50%          ^82^Rubidium                        93%               75%               91%
  Sampson et al^37^        2007       102                59             37                  \>50%          ^82^Rubidium                        93%               83%               85%
  Bateman et al^11^        2006       85                 52             65                  \>50%          ^99m^Tc-sestamibi                   82%               73%               79%
  Elhendy et al^21^        2001       332                77             57                  \>50%          ^99m^Tc-sestamibi                   77%               74%               77%
  Leoncini et al^22^       2001       33                 93             37                  NA             ^99m^Tc-sestamibi                   85%               55%               NA
  Nakamura et al^23^       1999       81                 80             37                  \>50%          ^201^Thallium & ^99m^Tc-sestamibi   83%               99%               95%
  Levine et al^24^         1999       50                 76             36                  NA             ^99m^Tc-sestamibi                   86%               55%               85%
  Milavetz et al^25^       1998       209                77             36.5                \>50%          ^99m^Tc-sestamibi                   95%               73%               88%
  Williams et al^29^       1994       287                75             NA                  \>50%          ^82^Rubidium                        87%               88%               88%
  Simone et al^30^         1992       225                80             NA                  \>50%          ^82^Rubidium                        92%               91%               91%
  Marwick et al^31^        1992       74                 NA             34                  \>50%          ^82^Rubidium                        90%               100%              91%
  Grover-McKay et al^32^   1992       31                 84             34.5                \>50%          ^82^Rubidium                        100%              73%               87%
  Stewart et al^26^        1991       81                 64.3           35                  \>50%          ^201^Thallium                       87%               53%               78%
  Go et al^27^             1990       202                NA             NA                  \>50%          ^201^Thallium                       76%               80%               77%
  Demer et al^33^          1989       193                74.1           NA                  \>50%          ^82^Rubidium & ^13^N ammonia        83%               95%               85%
  Tamaki et al^28^         1988       51                 NA             56.1                \>50%          ^201^Thallium                       81%               92%               NA
  Gould et al^34^          1986       50                 NA             NA                  \>50%          ^82^Rubidium & ^13^N ammonia        95%               100%              97%

NA-not available

The degree of coronary artery stenosis was assessed based on the criterion of \>50%, which was determined by invasive coronary angiography in all studies. Of these 20 studies, 82Rubidium was the most commonly-used radiopharmaceutical which was utilised in 10 studies \[[@R26]--[@R28], [@R30]--[@R33], [@R36]--[@R38]\]; 99mTc-Sestamibi was used in seven studies \[[@R19]--[@R21], [@R23], [@R24], [@R26], [@R41]\]; 201Thallium was used in four studies \[[@R25], [@R26], [@R28], [@R29]\]; a combination of 201Thallium and 99mTc-Sestamibi was used in one study \[[@R22]\]; 99mTc-Tetrofosmin was used in three studies \[[@R39], [@R40], [@R43]\]; and combinations of 13N Ammonia and 82Rubidium were used in the remaining two studies \[[@R34], [@R35]\].

Analysis of diagnostic value of SPECT in CAD {#s3a}
--------------------------------------------

A total of 2,208 patients were included in 15 SPECT studies based on significant CAD which was determined by visual assessment of coronary angiography. [Figure 2](#F2){ref-type="fig"} shows the mean sensitivity, specificity and accuracy of SPECT for diagnosis of CAD. As shown in the figure, the diagnostic value of SPECT was moderate when compared to invasive coronary angiography.

![Flow chart shows the searching strategy of eligible references.](biij-07-e9-g01){#F1}

![Overall pooled mean diagnostic value of SPECT, PET and PET/CT for detection of coronary artery disease.](biij-07-e9-g02){#F2}

Analysis of diagnostic value of PET in CAD {#s3b}
------------------------------------------

1,376 patients were included in another 11 studies performed with PET tests based on significant CAD which was determined by visual assessment of coronary angiography. [Figure 2](#F2){ref-type="fig"} shows the mean sensitivity, specificity and accuracy of PET for diagnosis of CAD. As shown in the figure, PET imaging was found to have high diagnostic value in the detection of CAD.

Analysis of diagnostic value of PET/CT in CAD {#s3c}
---------------------------------------------

518 patients were included in four studies performed with PET/CT studies based on significant CAD which was determined by visual assessment of coronary angiography. Again [Figure 2](#F2){ref-type="fig"} demonstrates that moderate sensitivity, specificity and accuracy of SPECT were reached for diagnosis of CAD.

Comparison of SPECT, PET and PET/CT {#s3d}
-----------------------------------

There is a significant difference in sensitivity, specificity and accuracy between PET and SPECT, PET and PET/CT, SPECT and PET/CT for the diagnosis of CAD (p \< 0.05), with PET demonstrating the highest diagnostic value among these three imaging modalities as shown in [Figure 2](#F2){ref-type="fig"}.

Analysis of diagnostic value for assessment of individual coronary artery disease {#s3e}
---------------------------------------------------------------------------------

[Table 2](#T2){ref-type="table"} demonstrates the diagnostic value of SPECT, PET and PET/CT in three studies with five comparisons based on analysis of three main coronary arteries.

###### 

Mean diagnostic value of SPECT, PET and PET/CT for detection of coronary artery disease by individual coronary branches.

  **Individual vessel CAD using 50% stenosis**   **Radiotracer**                   **Sensitivity**                   **Specificity**   **Accuracy**                                  
  ---------------------------------------------- --------------------------------- --------------------------------- ----------------- -------------- ----- ----- -- -- -- ---- ---- --
  Bateman et al^11^ \>50% stenosis               ^99m^Tc-sestamibi/ ^82^Rubidium   ^99m^Tc-sestamibi/ ^82^Rubidium                                                                   
  LAD                                            61%                               79%                               92%               95%            75%   87%                      
  LCx                                            33%                               58%                               86%               93%            68%   79%                      
  RCA                                            60%                               58%                               87%               100%           73%   78%                      
  Tamaki et al^28^ \>50% stenosis                ^201^Thallium/ ^13^N ammonia      ^201^Thallium/ ^13^N ammonia                                                            NA   NA   
  LAD                                            90%                               93%                               89%               100%                                          
  LCx                                            65%                               85%                               93%               90%                                           
  RCA                                            79%                               76%                               95%               86%                                           
  Cesar et al^36^ \>50% stenosis                                                                                     ^82^Rubidium                                                    
  LAD                                            70%                               69%                               70%                                                             
  LCx                                            76%                               86%                               83%                                                             
  RCA                                            66%                               92%                               77%                                                             

[Figures 3](#F3){ref-type="fig"} to [5](#F5){ref-type="fig"} demonstrate the overall results of sensitivity, specificity and accuracy analysed with three different nuclear medicine modalities at left anterior descending (LAD), left circumflex (LCx) and right coronary artery (RCA). As shown in the figures, PET has the highest diagnostic value among the 3 imaging modalities for diagnosis of CAD.

![Pooled diagnostic value of SPECT for detection of coronary artery disease based on individual coronary artery assessment.](biij-07-e9-g03){#F3}

![Pooled diagnostic value of PET for detection of coronary artery disease based on individual coronary artery assessment.](biij-07-e9-g04){#F4}

![Pooled diagnostic value of PET/CT for detection of coronary artery disease based on individual coronary artery assessment.](biij-07-e9-g05){#F5}

Analysis of effects of different Radiotracers on diagnostic value {#s3f}
-----------------------------------------------------------------

Since different types of radiotracers were used in these 20 studies, analyses of the diagnostic value of variable radiotracers for detection of CAD were investigated. [Table 3](#T3){ref-type="table"} shows the radiotracers used in these studies and their corresponding diagnostic value. As demonstrated in the table, using ammonia as a radiotracer produced the highest diagnostic value for detection of CAD.

###### 

Mean diagnostic value of nuclear medicine imaging with use of different radiotracers.

  **Radiotracer**                     **Patient**   **Male**   **Mean age**   **Stenosis**   **Sensitivity**          **Specificity**           **Accuracy**
  ----------------------------------- ------------- ---------- -------------- -------------- ------------------------ ------------------------- ------------------------
  ^201^Thallium                       414           74.6       42.3           50%            80%(95% CI: 74 to 86 )   77%(95% CI: 71 to 83 )    78%(95% CI: 72 to 84 )
  ^99m^Tc-sestamibi                   760           76.6       45.7           50%            86%(95% CI: 80 to 92 )   66%(95% CI: 60 to 72 )    83%(95% CI: 77 to 89 )
  ^201^Thallium & ^99m^Tc-sestamibi   81            80         37             50%            83%(95% CI: 77 to 89 )   99%(95% CI: 93 to 100 )   95%
  ^13^N ammonia                       121           71         42.5           50%            92%(95% CI: 86 to 98 )   86%(95% CI: 80 to 92 )    90%(95% CI: 84 to 96 )
  ^82^Rubidium                        985           71         42.5           50%            90%(95% CI: 84 to 96 )   88%(95% CI: 82 to 94 )    92%(95% CI: 86 to 98 )
  ^82^Rubidium & ^13^N ammonia        243           74         NA             50%            89%(95% CI: 83 to 95)    97%(95% CI: 91 to 100 )   91%(95% CI: 75 to 87 )

[Figure 6](#F6){ref-type="fig"} shows the differences in sensitivity and specificity between both 201Thallium and 99mTc-sestamibi for the diagnosis of CAD (p \< 0.05), and also significant differences in the specificity and accuracy between both 201Thallium and 99mTc-sestamibi and individual radiotracers for the diagnosis of CAD (p \< 0.05).

![Pooled diagnostic value of nuclear medicine imaging with use of variable radiotracers for detection of coronary artery disease.](biij-07-e9-g06){#F6}

Significant differences in sensitivity and accuracy was found between 13N ammonia, 82Rubidium and both 13N ammonia with 82Rubidium for the diagnosis of CAD (p \< 0.05) as shown in [Figure 6](#F6){ref-type="fig"}. Significant differences were found in the sensitivity and specificity between use of combined radiotracers (13N ammonia and 82Rubidium, 201Thallium and 99mTc-sestamibi) and use of individual radiotracers alone for the diagnosis of CAD (p \< 0.05).

DISCUSSION {#s4}
==========

This systematic review presents three significant findings which are considered to be important from a clinical perspective. First, the diagnostic value of SPECT and PET/CT in the detection of CAD is moderate when compared to invasive coronary angiography. Second, PET has higher sensitivity and specificity than SPECT or PET/CT for detection of CAD, indicating the increasing diagnostic accuracy of PET in cardiac imaging. Lastly, there are significant differences when different radiotracers are used for the diagnosis of CAD, with the use of combined radiotracers resulting in improved diagnostic value.

SPECT has been used as a routine technique in clinical practice for myocardial perfusion imaging for decades \[[@R28]\]. Previous studies have shown that the diagnostic value of SPECT in cardiac imaging is variable, ranging from low to moderate \[[@R29]\]. Di Carli et al. \[[@R44]\] compared three studies using SPECT with PET, looking particularly at the diagnostic accuracy for detection of CAD. Only the sensitivity and specificity were provided in their study while the analysis of diagnostic accuracy was not identified. This analysis confirms their results to a greater extent, as the mean sensitivity, specificity and accuracy of SPECT for detection of CAD are moderate. This indicates that SPECT has not reached the diagnostic accuracy to be considered as a reliable technique for assessment of CAD.

PET has been used more recently in cardiac imaging, and early results look promising \[[@R45]\]. PET offers potential advantages in a clinical practice over myocardial perfusion scintigraphy \[[@R46]\]. PET is able to assess myocardial blood flow and is superior in detecting multivessel disease \[[@R47]\]. Our analysis identifies PET as having the highest diagnostic value for CAD among the three different nuclear imaging modalities analysed. Husmann et al. \[[@R26]\] compared SPECT and PET in respect to diagnostic accuracy of myocardial perfusion imaging. Only the sensitivity and specificity were reported in their study, while the diagnostic accuracy was not available. In contrast, the sensitivity, specificity and accuracy of PET for detection of CAD were analysed in our report. This review provides a comprehensive analysis of the diagnostic value of these nuclear modalities, including sensitivity, specificity and accuracy. Thus, it is believed that the analysis offers additional and valuable diagnostic information, as compared to the previous reports in the literature.

Recently, cardiac imaging has been further enhanced by the use of integrated PET/CT, a combined modality which provides the considerable benefit of anatomical and physiologic assessment in patients with CAD \[[@R36], [@R37]\]. PET/CT allows precise detection and localisation of CAD \[[@R38]\]. CT coronary angiography provides superior anatomical details but lacks the functional information of cardiac perfusion. The latest refinements in CT technology, including multidetector CT with faster gantry rotations, and dual-source devices, have advanced CT angiography as a promising alternative to conventional angiography in the diagnosis of CAD selected patients \[[@R48]\]. Recent studies have shown that 64-slice CTA has high sensitivity (73%- 100%) and specificity (90%-90%) in the detection of CAD \[[@R49]--[@R51]\]. PET offers evidence of sub-clinical coronary atherosclerosis as it is superior in demonstrating metabolic activities, but its spatial resolution is limited when demonstrating coronary anatomical structures \[[@R47]\]. Thus, combined PET/CT overcomes the limitations of each individual modality while maximising the advantages of both PET and CT in cardiac imaging \[[@R44]--[@R46]\].

However, the analysis of integrated PET/CT for detection of CAD was not as good as initially expected since PET/CT was shown to have moderate sensitivity, specificity and accuracy. This may be due to the selection of patients with different risk factors in the studies analysed. Therefore, results of this analysis should be interpreted with caution. PET/CT may show improved diagnostic accuracy in other areas, such as tumour imaging, but not in the diagnosis of CAD, based on this analysis.

This analysis also involves a comparison of radiotracers used in SPECT and PET imaging which includes seven different types of radioisotopes, namely 201Thallium, 99mTc-tetrofosmin, 99mTc-Sestamibi, a combination of 201Thallium and 99mTc-Sestamibi, 13N Ammonia, 82Rubidium, and a combination of 13N Ammonia and 82Rubidium. The comparative analysis indicates significant benefits of using 13N ammonia for MPI to detect CAD by PET, leading to the highest sensitivity and accuracy. Both 13N ammonia and 82Rubidium have significantly high specificity in MPI by PET. PET imaging with use of 13N ammonia, 82Rubidium, and a combination of 13N ammonia and 82Rubidium for diagnosis of CAD, has been found to result in significant differences in sensitivity, specificity and accuracy than those using 201Thallium, 99mTc-sestamibi, and a combination of 201Thallium and 99mTc-sestamibi by SPECT imaging. This is consistent with results reported by other studies. Go and colleagues \[[@R28]\] compared PET and SPECT in 202 patients. Their results showed there was no significant difference between PET imaging with use of 82Rubidium and SPECT imaging with 201Thallium. Tamaki and colleagues \[[@R29]\] compared 13N ammonia PET with 201Thallium SPECT and reported similar findings. Hence, this analysis confirms that 13N ammonia PET and 201Thallium SPECT provide high diagnostic value for detection of CAD.

In addition, the analysis of individual coronary arteries demonstrates the superiority of PET over the other two modalities, but a significant difference in diagnostic value was only found between PET and SPECT, PET/CT in LAD. PET/CT was found to be significantly higher than PET in the assessment of RCA in terms of diagnostic accuracy. However, only a few studies presented the analysis of individual coronary arteries, thus a robust conclusion cannot be drawn based on the current analyses.

There were some limitations identified in this study which need to be addressed. First, most of the studies did not provide detailed numbers of true positive, true negative cases, thus this prevented the authors from performing an accurate analysis of the diagnostic value of these modalities. Second, studies currently under review or submitted for publication were not included, although the authors did try to cover as many articles as possible in the search. Third, diagnostic value reported in each study was dependent on the radiotracers used, thus results should be interpreted with caution. Fourth, there exists variability among readers to interpret the angiographic images in terms of the degree of stenosis, for example, 50% or more stenosis \[[@R52]\]. Last, this analysis was restricted to English language literature, which could introduce biased opinion to the results. PET/CT has more potential advantages because it integrated two modalities but not many studies were found.

In conclusion, this analysis shows that PET has higher sensitivity, specificity and accuracy for detection of CAD than SPECT and PET/CT. PET can be used as a reliable, less invasive modality for functional analysis of patients suspected of CAD. Further studies comprising a large sample size are needed to verify these results.
